E
Prime Medicine, Inc. PRME
$3.69 $0.13883.91% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 4.95% -13.39% 35.60% -3.57% -30.53%
Total Depreciation and Amortization 21.20% 29.28% 37.69% 26.05% 37.57%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -32.80% 31.18% 30.61% 0.82% 116.30%
Change in Net Operating Assets 111.54% 74.58% 238.13% 611.80% 14.98%
Cash from Operations 8.97% 27.84% 137.03% 33.84% -11.44%
Capital Expenditure 17.35% -4.22% 2.66% 56.10% 3.74%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -50.63% -30.58% 16.04% 248.07% -70.52%
Cash from Investing -59.81% -28.92% 16.88% 233.29% -75.26%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 462.86% -- -99.48% 12,011.01% -53.33%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -75.81% -- -- --
Cash from Financing 462.86% -96.19% -99.48% 12,011.01% -53.33%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 0.31% -272.28% 2,804.36% 182.15% -199.28%